These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Under the lens: diabetic retinopathy. The Lancet Diabetes Endocrinology Lancet Diabetes Endocrinol; 2020 Nov; 8(11):869. PubMed ID: 33038294 [No Abstract] [Full Text] [Related]
24. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. Jamal-u-Din ; Qureshi MB; Khan AJ; Khan MD; Ahmad K J Ayub Med Coll Abbottabad; 2006; 18(3):40-3. PubMed ID: 17348311 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of diabetic retinopathy following a community screening for diabetes. Paudyal G; Shrestha MK; Meyer JJ; Thapa R; Gurung R; Ruit S Nepal Med Coll J; 2008 Sep; 10(3):160-3. PubMed ID: 19253859 [TBL] [Abstract][Full Text] [Related]
27. [Development of the medical treatment of diabetes in Luxembourg]. Perquin M; Keipes M; Wirion R; Haas N; de Beaufort CE; Michel GH Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):29-35. PubMed ID: 16869094 [TBL] [Abstract][Full Text] [Related]
28. Screening for diabetic retinopathy: a comparative study between hospital and community based screening and between paying and non-paying patients. Afghani T; Qureshi N; Chaudhry KS J Ayub Med Coll Abbottabad; 2007; 19(1):16-22. PubMed ID: 17867473 [TBL] [Abstract][Full Text] [Related]
29. To screen or not to screen? High-tech responses to a not-so-hamletic question. Porta M Diabetes Metab; 2008 Jun; 34(3):189-91. PubMed ID: 18468931 [No Abstract] [Full Text] [Related]
30. Prevalence and risk factors for diabetic retinopathy--a study of 217 patients from University of Malaya Medical Centre. Tajunisah I; Nabilah H; Reddy SC Med J Malaysia; 2006 Oct; 61(4):451-6. PubMed ID: 17243523 [TBL] [Abstract][Full Text] [Related]
31. [Current guidelines in the treatment of diabetic retinopathy]. Carreras y Matas M Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(163):169-77. PubMed ID: 5401125 [No Abstract] [Full Text] [Related]
32. Diabetic retinopathy: current management and experimental therapeutic targets. Ali TK; El-Remessy AB Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588 [TBL] [Abstract][Full Text] [Related]
33. Prevention of type 2 DM: implications for adolescents and young adults. Karam JG; McFarlane SI Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():980-8. PubMed ID: 18806714 [TBL] [Abstract][Full Text] [Related]
34. Microvascular complications in cystic fibrosis-related diabetes. Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485 [TBL] [Abstract][Full Text] [Related]
35. For the patient. Preparing diabetes education materials for targeted groups. Ethn Dis; 2006; 16(4):1011-2. PubMed ID: 17063582 [No Abstract] [Full Text] [Related]
36. Dermopathy and retinopathy in diabetes: is there an association? Abdollahi A; Daneshpazhooh M; Amirchaghmaghi E; Sheikhi S; Eshrati B; Bastanhagh MH Dermatology; 2007; 214(2):133-6. PubMed ID: 17341862 [TBL] [Abstract][Full Text] [Related]
37. Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes. Soto-Pedre E; Hernaez-Ortega MC; Piniés JA Ophthalmic Epidemiol; 2007; 14(2):76-9. PubMed ID: 17464854 [TBL] [Abstract][Full Text] [Related]
38. Periodontal disease and diabetes. Nelson RG Oral Dis; 2008 Apr; 14(3):204-5. PubMed ID: 18336371 [No Abstract] [Full Text] [Related]
40. [Diabetes half-way between type 1 and type 2. LADA--the second biggest diabetic group where best treatment is uncertain]. Björklund A; Grill V; Carlsson S; Groop L Lakartidningen; 2008 May 21-27; 105(21):1568-70. PubMed ID: 18574993 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]